Biosynthesis of cholesterol: Difference between revisions
No edit summary |
No edit summary |
||
(36 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' scene='HMG-CoA_Reductase/1dq8_starting_scene/1' caption='Crystal Structure of HMG-CoA, (PDB code [[1dq8]])'> | <StructureSection load='' size='350' side='right' scene='HMG-CoA_Reductase/1dq8_starting_scene/1' caption='Crystal Structure of HMG-CoA, (PDB code [[1dq8]])'> | ||
Synthesis within the body starts with the mevalonate pathway where two molecules of acetyl CoA condense to form acetoacetyl-CoA. This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl CoA (HMG-CoA). This molecule is then reduced to mevalonate by the enzyme [[HMG-CoA reductase]]. Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. | Synthesis within the body starts with the mevalonate pathway where two molecules of <scene name='43/430893/Cv/2'>acetyl-CoA</scene> condense to form <scene name='92/929923/Cv/1'>acetoacetyl-CoA</scene>. This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form <scene name='92/929923/Cv/2'>3-hydroxy-3-methylglutaryl CoA (HMG-CoA)</scene>. This molecule is then reduced to <scene name='92/929923/Cv/3'>mevalonate</scene> by the enzyme [[HMG-CoA reductase]]. Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. | ||
'''Mevalonate pathway''' | |||
''Acetoacetyl-CoA thiolase'' | |||
*[[Acetoacetyl-CoA thiolase]] | |||
2 <scene name='43/430893/Cv/2'>acetyl-CoA</scene> => <scene name='92/929923/Cv/1'>acetoacetyl-CoA</scene>. | |||
''Hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase; EC 2.3.3.10'' | |||
*[[1xpk]] | |||
<scene name='43/430893/Cv/2'>Acetyl-CoA</scene> + <scene name='92/929923/Cv/1'>acetoacetyl-CoA</scene> => <scene name='92/929923/Cv/2'>3-hydroxy-3-methylglutaryl CoA (HMG-CoA)</scene>. | |||
''HMG-CoA Reductase'' | |||
*[[HMG-CoA Reductase]] | |||
<scene name='92/929923/Cv/2'>3-hydroxy-3-methylglutaryl CoA (HMG-CoA)</scene> => <scene name='92/929923/Cv/3'>mevalonate</scene> | |||
The HMG binding pocket is the site of catalysis in HMGR. <scene name='HMG-CoA_Reductase/1dqa_cis_loop2/2'> The “cis-loop” that bends over the top of HMG </scene> ([[1dqa]]) is a critical structural element of this binding site. Residues <scene name='HMG-CoA_Reductase/1dqa_e_and_d/2'>E559 and D767</scene> and are positioned in the active site as is <scene name='HMG-CoA_Reductase/1dqa_k691/2'>K691 which is only 2.7 angstroms from the HMG O2 carbonyl oxygen</scene>. It is this K691 that likely stabilizes the negatively charged oxygen of the first mevaldyl-CoA intermediate. The mevaldyl CoA intermediate is subsequently converted to Mavaldehyde with added stabilization from <scene name='HMG-CoA_Reductase/1dqa_h866/2'>H866, which is within hydrogen bonding distance of the thiol group</scene>. It is then believed that the close proximity of <scene name='HMG-CoA_Reductase/1dqa_e_and_d/2'>E559 and D767</scene> increases the pKA of E559, allowing it to be a proton donor for the reduction of mevaldehyde into mevalonate. | |||
''Mevalonate kinase'' | |||
*[[Mevalonate kinase]] | |||
<scene name='92/929923/Cv/3'>mevalonate</scene> => <scene name='92/929923/Cv/6'>mevalonate-5-phosphate</scene> | |||
The 3D structure of MK complex with mevalonate shows the enzyme composed of <scene name='86/864102/Cv/2'>2 domains</scene>: The N-terminal and the C-terminal. The mevalonate binds in a <scene name='86/864102/Cv/7'>deep cleft</scene> between the 2 domains forming <scene name='86/864102/Cv/6'>H-bonds and hydrophobic interactions</scene><ref>PMID:17397541</ref>. Water molecules are shown as red spheres. | |||
''Phosphomevalonate kinase'' | |||
*The Crystal Structure of Human Phosphomavelonate Kinase At 1.8 A Resolution [[3ch4]] | |||
<scene name='92/929923/Cv/6'>mevalonate-5-phosphate</scene> => <scene name='92/929923/Cv/7'>mevalonate-5-pyrophosphate</scene> | |||
''Mevalonate-5-pyrophosphate decarboxylase'' | |||
Diphosphomevalonate decarboxylase (EC 4.1.1.33), most commonly referred to in scientific literature as mevalonate diphosphate decarboxylase. | |||
*[[Sandbox Reserved 333|Mevalonate Diphosphate Decarboxylase]] | |||
<scene name='92/929923/Cv/7'>mevalonate-5-pyrophosphate</scene> => <scene name='92/929923/Cv/8'>isopentenyl pyrophosphate</scene> | |||
''Isopentenyl pyrophosphate isomerase'' | |||
Isopentenyl pyrophosphate isomerase (EC 5.3.3.2, IPP isomerase), also known as Isopentenyl-diphosphate delta isomerase | |||
*[[Isopentenyl-diphosphate delta-isomerase]] | |||
<scene name='92/929923/Cv/8'>isopentenyl pyrophosphate</scene> => <scene name='92/929923/Cv/9'>dimethylallyl pyrophosphate</scene> | |||
'''Next steps of Cholesterol Biosynthesis''' | |||
''Geranyl transferase'' | |||
Three molecules of <scene name='92/929923/Cv/8'>isopentenyl pyrophosphate</scene> condense to form <scene name='92/929923/Cv/10'>farnesyl pyrophosphate</scene> through the action of geranyl transferase. Other names in common use include: | |||
*farnesyl-diphosphate synthase | |||
*geranyl transferase I | |||
*prenyltransferase | |||
*farnesyl pyrophosphate synthetase | |||
*farnesylpyrophosphate synthetase | |||
*[[Farnesyl diphosphate synthase]] | |||
''Squalene synthase'' | |||
Two molecules of <scene name='92/929923/Cv/10'>farnesyl pyrophosphate</scene> then condense to form <scene name='92/929923/Cv/11'>squalene</scene> by the action of squalene synthase in the endoplasmic reticulum. | |||
*[[Squalene synthase]] | |||
''Oxidosqualene cyclase'' | |||
Oxidosqualene cyclase then cyclizes squalene to form lanosterol. | |||
*[[Squalene-hopene cyclase]] | |||
Finally, <scene name='92/929923/Cv/5'>lanosterol</scene> is converted to <scene name='92/929923/Cv/4'>cholesterol</scene> via either of two pathways, the Bloch pathway, or the Kandutsch-Russell pathway. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> |
Latest revision as of 12:38, 11 December 2022
Synthesis within the body starts with the mevalonate pathway where two molecules of condense to form . This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form . This molecule is then reduced to by the enzyme HMG-CoA reductase. Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. Mevalonate pathway Acetoacetyl-CoA thiolase 2 => . Hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase; EC 2.3.3.10 + => . HMG-CoA Reductase => The HMG binding pocket is the site of catalysis in HMGR. (1dqa) is a critical structural element of this binding site. Residues and are positioned in the active site as is . It is this K691 that likely stabilizes the negatively charged oxygen of the first mevaldyl-CoA intermediate. The mevaldyl CoA intermediate is subsequently converted to Mavaldehyde with added stabilization from . It is then believed that the close proximity of increases the pKA of E559, allowing it to be a proton donor for the reduction of mevaldehyde into mevalonate. Mevalonate kinase => The 3D structure of MK complex with mevalonate shows the enzyme composed of : The N-terminal and the C-terminal. The mevalonate binds in a between the 2 domains forming [1]. Water molecules are shown as red spheres. Phosphomevalonate kinase
=> Mevalonate-5-pyrophosphate decarboxylase Diphosphomevalonate decarboxylase (EC 4.1.1.33), most commonly referred to in scientific literature as mevalonate diphosphate decarboxylase. => Isopentenyl pyrophosphate isomerase Isopentenyl pyrophosphate isomerase (EC 5.3.3.2, IPP isomerase), also known as Isopentenyl-diphosphate delta isomerase => Next steps of Cholesterol Biosynthesis Geranyl transferase Three molecules of condense to form through the action of geranyl transferase. Other names in common use include:
Squalene synthase Two molecules of then condense to form by the action of squalene synthase in the endoplasmic reticulum. Oxidosqualene cyclase Oxidosqualene cyclase then cyclizes squalene to form lanosterol. Finally, is converted to via either of two pathways, the Bloch pathway, or the Kandutsch-Russell pathway. |
|
ReferencesReferences
- ↑ Sgraja T, Smith TK, Hunter WN. Structure, substrate recognition and reactivity of Leishmania major mevalonate kinase. BMC Struct Biol. 2007 Mar 30;7:20. PMID:17397541 doi:10.1186/1472-6807-7-20